Construction contract (Icosagen AS GMP manufacturing facility)
October 18 2022 - 2:00AM
Construction contract (Icosagen AS GMP manufacturing facility)
AS Nordecon group company Embach Ehitus OÜ and
ICO Park OÜ signed a contract for the construction of the Icosagen
AS GMP manufacturing facility located in Eerika tee 1, Õssu
village, Kambja municipality. The new manufacturing facility is
1,600 m2 in size and composed of two functional parts –
laboratories and cell culture rooms are designed to be on the
ground floor, and the production unit with clean room conditions
for the production of biological drug candidates for clinical
trials will be on the second floor.
The cost of the works is appr. 4 million euros
plus value added tax. The entire building with the cGMP part will
be completed in June 2023.
Nordecon (www.nordecon.com) is a group of
construction companies whose core business is construction project
management and general contracting in the buildings and
infrastructures segment. Geographically the Group operates in
Estonia, Finland, Ukraine and Sweden. The parent of the Group is
Nordecon AS, a company registered and located in Tallinn, Estonia.
The consolidated revenue of the Group in 2021 was 289 million
euros. Currently Nordecon Group employs close to 670 people. Since
18 May 2006 the company's shares have been quoted in the main list
of the Nasdaq Tallinn Stock Exchange.
Andri HõbemägiNordecon ASHead of Investor
RelationsTel: +372 6272 022E-mail: andri.hobemagi@nordecon.com
www.nordecon.com
Nordecon As (LSE:0NZ8)
Historical Stock Chart
From Oct 2024 to Nov 2024
Nordecon As (LSE:0NZ8)
Historical Stock Chart
From Nov 2023 to Nov 2024
